Extract from the Register of European Patents

EP About this file: EP1621540

EP1621540 - NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USE THEREOF [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  06.02.2009
Database last updated on 21.03.2026
Most recent event   Tooltip06.02.2009Withdrawal of applicationpublished on 11.03.2009  [2009/11]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[N/P]
Former [2006/05]For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome, Chuo-ku Osaka-shi
Osaka 541-8526 / JP
Inventor(s)01 / Nishizawa, Rena, c/o Ono Pharmaceutical Co. Ltd
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
02 / Takaoka, Yoshikazu, c/o Ono Pharmaceutical Co. Ltd
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
03 / Shibayama, Shiro, c/o Ono Pharmaceutical Co. Ltd
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
 [2006/05]
Representative(s)Henkel & Partner mbB
Patentanwaltskanzlei, Rechtsanwaltskanzlei
Maximiliansplatz 21
80333 München / DE
[N/P]
Former [2006/05]Henkel, Feiler & Hänzel
Patentanwälte Maximiliansplatz 21
80333 München / DE
Application number, filing date04728443.520.04.2004
[2006/05]
WO2004JP05610
Priority number, dateJP2003011623521.04.2003         Original published format: JP 2003116235
[2006/05]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004094424
Date:04.11.2004
Language:EN
[2004/45]
Type: A1 Application with search report 
No.:EP1621540
Date:01.02.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 04.11.2004 takes the place of the publication of the European patent application.
[2006/05]
Search report(s)International search report - published on:JP04.11.2004
(Supplementary) European search report - dispatched on:EP19.06.2008
ClassificationIPC:C07D471/10, A61K31/499, A61P11/06, A61P13/12, A61P1/16, A61P19/02, A61P11/02, A61P27/02, A61P1/04, A61P37/02, A61P17/06, A61P31/18, A61P37/08, A61P9/10, A61P11/00, A61P35/04, A61P3/10
[2006/05]
CPC:
C07D471/10 (EP,US); A61K31/499 (EP,US); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P27/02 (EP); A61P3/10 (EP);
A61P31/12 (EP); A61P31/18 (EP); A61P35/04 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/05]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:STICKSTOFFHALTIGE HETEROCYCLISCHE VERBINDUNGEN UND DEREN VERWENDUNGEN[2006/05]
English:NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USE THEREOF[2006/05]
French:COMPOSES HETEROCYCLIQUES CONTENANT DE L'AZOTE ET UTILISATION DE CELUI-CI[2006/05]
Entry into regional phase21.11.2005Translation filed 
21.11.2005National basic fee paid 
21.11.2005Search fee paid 
21.11.2005Designation fee(s) paid 
21.11.2005Examination fee paid 
Examination procedure21.11.2005Amendment by applicant (claims and/or description)
21.11.2005Examination requested  [2006/05]
28.01.2009Application withdrawn by applicant  [2009/11]
Fees paidRenewal fee
27.04.2006Renewal fee patent year 03
27.04.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX] WO2004026873  (ONO PHARMACEUTICAL CO et al.) [PX] 1-16 * the whole document *
 [X]   ASIM KUMAR DEBNATH: "GENERATION OF PREDICTIVE PHARMACOPHORE MODELS FOR CCR5 ANTAGONISTS: STUDY WITH PIPERIDINE- AND PIPERAZINE-BASED COMPOUNDS AS A NEW CLASS OF HIV-1 ENTRY INHIBITORS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, vol. 46, 1 January 2003 (2003-01-01), pages 4501 - 4515, XP002330164, ISSN: 0022-2623 [X] 1-3,7-16 * page 4501; table 5; compound 109 *

DOI:   http://dx.doi.org/10.1021/jm030265z
International search[X]   MAEDAA K. ET AL.: "Novel low molecular weight spirodiketopiprazin derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 37, 2001, pages 35194 - 35200, XP002951814 [X]

DOI:   http://dx.doi.org/10.1074/jbc.M105670200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.